1. Home
  2. ADVM vs MOGO Comparison

ADVM vs MOGO Comparison

Compare ADVM & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • MOGO
  • Stock Information
  • Founded
  • ADVM 2006
  • MOGO 2003
  • Country
  • ADVM United States
  • MOGO Canada
  • Employees
  • ADVM N/A
  • MOGO N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • MOGO
  • Sector
  • ADVM Health Care
  • MOGO
  • Exchange
  • ADVM Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • ADVM 47.4M
  • MOGO 48.3M
  • IPO Year
  • ADVM 2014
  • MOGO N/A
  • Fundamental
  • Price
  • ADVM $2.74
  • MOGO $1.91
  • Analyst Decision
  • ADVM Strong Buy
  • MOGO Strong Buy
  • Analyst Count
  • ADVM 5
  • MOGO 1
  • Target Price
  • ADVM $23.80
  • MOGO $4.00
  • AVG Volume (30 Days)
  • ADVM 297.2K
  • MOGO 14.7M
  • Earning Date
  • ADVM 08-11-2025
  • MOGO 08-07-2025
  • Dividend Yield
  • ADVM N/A
  • MOGO N/A
  • EPS Growth
  • ADVM N/A
  • MOGO N/A
  • EPS
  • ADVM N/A
  • MOGO N/A
  • Revenue
  • ADVM $1,000,000.00
  • MOGO $28,873,274.00
  • Revenue This Year
  • ADVM N/A
  • MOGO $59.16
  • Revenue Next Year
  • ADVM $18.82
  • MOGO $6.17
  • P/E Ratio
  • ADVM N/A
  • MOGO N/A
  • Revenue Growth
  • ADVM N/A
  • MOGO 0.62
  • 52 Week Low
  • ADVM $1.78
  • MOGO $0.74
  • 52 Week High
  • ADVM $10.14
  • MOGO $3.83
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 59.62
  • MOGO 57.64
  • Support Level
  • ADVM $2.50
  • MOGO $1.87
  • Resistance Level
  • ADVM $2.75
  • MOGO $2.12
  • Average True Range (ATR)
  • ADVM 0.20
  • MOGO 0.27
  • MACD
  • ADVM 0.06
  • MOGO 0.00
  • Stochastic Oscillator
  • ADVM 82.50
  • MOGO 27.82

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

Share on Social Networks: